Article Per Year (5 Year)
p-Index From 2019 - 2024
0.23
P-Index
This Author published in this journals
All Journal PHARMACON
Grenshannya Anasthasya Pua
Sam Ratulangi University
Medicine & Pharmacology

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
Review Virus Chikungunya Grenshannya Anasthasya Pua; Fatimawali Fatimawali; Irma Antasionasti
PHARMACON Vol. 11 No. 3 (2022): PHARMACON
Publisher : UNIVERSITAS SAM RATULANGI

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Chikungunya is a virus belonging to the family Togaviridae and genus Alphavirus which was first isolated in Tanzania in 1953. This virus transmission by mosquito vectors, namely Aedes aygepti and Aedes albopictus. Indonesia itself is included as the country that has the largest burden of Chikungunya in Southeast Asia. Symptoms caused by this viral infection are severe enough to cause temporary paralysis and prolonged joint pain. Chikungunya virus drugs and vaccines are not yet officially available and are licensed only in the form of symptomatic treatment that can be given to reduce symptoms. Research and development of Chikungunya virus treatment and vaccines are currently being developed to control the spread of the Chikungunya virus. 
Co-Authors Fatimawali . Irma Antasionasti